Emerging therapeutic targets for soft tissue sarcoma.
Publication
, Journal Article
Smith, JL; Riedel, RF
Published in: Curr Oncol Rep
August 2011
Soft tissue sarcomas (STS) are malignancies of mesenchymal origin that represent approximately 1% of cancers in adults. Systematic research into the treatment of STS is challenging given its rarity and disease heterogeneity. Despite the ability to histologically subtype STS, only recently has our approach to therapy begun to differentiate along these lines. The purpose of this review is to highlight emerging therapeutic targets and therapies that hold the potential to add to the current state of systemic treatment for STS.
Duke Scholars
Published In
Curr Oncol Rep
DOI
EISSN
1534-6269
Publication Date
August 2011
Volume
13
Issue
4
Start / End Page
350 / 358
Location
United States
Related Subject Headings
- Sarcoma
- Oncology & Carcinogenesis
- Molecular Targeted Therapy
- Humans
- Cell Cycle
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Smith, J. L., & Riedel, R. F. (2011). Emerging therapeutic targets for soft tissue sarcoma. Curr Oncol Rep, 13(4), 350–358. https://doi.org/10.1007/s11912-011-0175-y
Smith, Jason L., and Richard F. Riedel. “Emerging therapeutic targets for soft tissue sarcoma.” Curr Oncol Rep 13, no. 4 (August 2011): 350–58. https://doi.org/10.1007/s11912-011-0175-y.
Smith JL, Riedel RF. Emerging therapeutic targets for soft tissue sarcoma. Curr Oncol Rep. 2011 Aug;13(4):350–8.
Smith, Jason L., and Richard F. Riedel. “Emerging therapeutic targets for soft tissue sarcoma.” Curr Oncol Rep, vol. 13, no. 4, Aug. 2011, pp. 350–58. Pubmed, doi:10.1007/s11912-011-0175-y.
Smith JL, Riedel RF. Emerging therapeutic targets for soft tissue sarcoma. Curr Oncol Rep. 2011 Aug;13(4):350–358.
Published In
Curr Oncol Rep
DOI
EISSN
1534-6269
Publication Date
August 2011
Volume
13
Issue
4
Start / End Page
350 / 358
Location
United States
Related Subject Headings
- Sarcoma
- Oncology & Carcinogenesis
- Molecular Targeted Therapy
- Humans
- Cell Cycle
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- 1112 Oncology and Carcinogenesis